I can't read something that isn't there. If you're right, which you aren't I would short the heck out if this thing because AF and crew would eat any such results for Christmas. The whole point of this trial is to confirm the incredibly small 2a trial parameters. Why would anyone chance the mess you're talking about? Someone posted an old article today where McFarlane was happy with 75% of patients already on donezepil on the last trial and now you say no. Are you kidding?
Market Data 
Markets 
AI
